StartUp Health Insights: Sami Closes $18M Series B and NEXT Leave a comment
Two StartUp Health companies — Sami and NEXT Life Sciences — closed funding rounds this week to support Brazilian healthcare and male contraception.
Investors, learn how you can back Health Transformers like the founders of Sami & NEXT Life Sciences.
This week’s funding included two StartUp Health companies taking on diverse health moonshot challenges.
Sami, a health insurance startup that aims to revolutionize the Brazilian private healthcare system, raised $18M in a Series B round led by Redpoint eventures and Mundi Ventures, with participation from Endeavor Catalyst, Didi Digital Horizon, Tau Ventures, Valor Capital, Mancora Ventures, and others. <source>
NEXT Life Sciences, a Los Angeles, CA-based company advancing Plan A™, a reversible contraceptive solution for men, raised $1.55M in Seed funding from undisclosed investors. <source>
Other health innovation funding reported this week included:
Strive Health, a Denver, CO-based company working to provide value-based care specifically for chronic kidney disease, raised $166M led by NEA and five new investors, including CVS Health Ventures, with participation from CapitalG (Alphabet), Echo Ventures, Town Hall Ventures, Ascension Ventures, and Redpoint. <source>
Helium Health, a Lagos, Nigeria-based health tech startup that provides SaaS tools, financing, and insights for healthcare providers and public health organizations, raised $30M led by AXA IM Alts, with participation from Capria Ventures, Angaza Capital, Flatworld Partners, Global Ventures, Tencent, Ohara Pharmaceuticals, LCY Group, WTI, AAIC, and others. <source>
Hyro, a New York, NY-based developer of a GPT-enabled conversational AI provider for healthcare, raised $20M led by Macquarie Capital, with participation from Liberty Mutual Strategic Ventures, Black Opal Ventures, and others. <source>
Axuall, a Cleveland, OH-based clinical workforce intelligence company for healthcare systems, staffing firms, telehealth, and health plans, raised $20M led by Noro-Moseley Partners, with participation from Flare Capital Partners, Intermountain Ventures, University Hospitals Ventures, Hartford HealthCare, LocumTenens.com, Epsilon Health Investors, InHealth Ventures, AV8 Ventures, JumpStart Ventures, and M25 Ventures. <source>
RxLightning, a New Albany, IN-based developer of a platform for streamlining specialty medication access and affordability, raised $17.5M led by LRVHealth, with participation from McKesson Ventures, Novartis (dRx Capital), Onco360 (BrightSpring Health Services), Hearst Ventures, and HealthX Ventures. <source>
Sensydia, a Los Angeles, CA-based non-invasive cardiac diagnostic company, raised a $3M NIH Grant. <source>
Develop Health, a San Francisco, CA-based startup focused on the medication prior authorization process, raised $1.8M from Afore Capital, South Park Commons, and angel investors. <source>
Grapefruit Health, a Chicago, IL-based startup that connects healthcare organizations with clinical students who can do tasks remotely, raised $1.3M from Antler, GoAhead Ventures, Hustle Fund, Litquidity, LongJump Ventures, SUM Ventures, Sweater, The Fund Midwest, and others. <source>
Spectacom Global, a New Delhi, India-based personal health and wellbeing company, raised 11 crores (~$1.3M) from Rainmatter Health. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
